-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KpLXHW398wl8ARw3QmdPOWLEl3MAmor764q5N23ejBlN5vFguWDOfIro95HJRL6+ sRCFFl8knJEURDmTfhmG6A== 0001116502-08-001804.txt : 20081106 0001116502-08-001804.hdr.sgml : 20081106 20081106171434 ACCESSION NUMBER: 0001116502-08-001804 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20080930 FILED AS OF DATE: 20081106 DATE AS OF CHANGE: 20081106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PARLUX FRAGRANCES INC CENTRAL INDEX KEY: 0000802356 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 222562955 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-15491 FILM NUMBER: 081168010 BUSINESS ADDRESS: STREET 1: 3725 S W 30TH AVE CITY: FT LAUDERDALE STATE: FL ZIP: 33312 BUSINESS PHONE: 9543169008 MAIL ADDRESS: STREET 1: 3725 S W 30TH AVENUE CITY: FT LAUDERDALE STATE: FL ZIP: 33312 10-Q 1 parlux10q.htm QUARTERLY REPORT United States Securities and Exchange Commission Edgar Filing


 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

———————

FORM 10-Q

———————

(Mark One)

ý

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: SEPTEMBER 30, 2008

Or

¨

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________ to ________

Commission File Number: 0-15491

PARLUX FRAGRANCES, INC.

(Exact name of registrant as specified in its charter)

______________

DELAWARE

22-2562955

(State or other jurisdiction of
incorporation or organization)

(IRS employer
identification no.)

5900 N. Andrews Avenue, Suite 500, Fort Lauderdale, FL 33309

(Address of principal executive offices) (Zip code)

(954) 316-9008

 (Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý  No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ¨   Accelerated filer ý   Non-accelerated filer ¨   Smaller reporting company ý

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨  No ý

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Class

Outstanding at November 5, 2008

Common Stock, $0.01 par value per share

20,528,812 shares

 

 

 




PART I. – FINANCIAL INFORMATION

UNAUDITED

Item 1.

Financial Statements.

See pages 14 to 29.

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Parlux Fragrances, Inc. is a manufacturer and international distributor of prestige products. It holds licenses for Paris Hilton fragrances, watches, cosmetics, sunglasses, handbags and other small leather accessories in addition to licenses to manufacture and distribute the designer fragrance brands of GUESS?, Jessica Simpson, Nicole Miller, Josie Natori, Queen Latifah, XOXO, Ocean Pacific (OP), Andy Roddick, babyGund, and Fred Hayman Beverly Hills.

Certain statements within this Quarterly Report on Form 10-Q, which are not historical in nature, including those that contain the words, “anticipate”; “believe”; “plan”; “estimate”; “expect”; “should”; “intend”; and other similar expressions, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All forward-looking statements are based on current expectations. Investors are cautioned that forward-looking statements involve many risks and uncertainties, which may affect our business and prospects, including economic, competitive, governmental and other factors included in our filings with the Securities and Exchange Commission (“SEC”), including the Risk Factors included in our Annual Report on Form 10-K for the year ended March 31, 2008. Accordingly, actual results may differ material ly from those expressed in the forward-looking statements, and the making of such statements should not be regarded as a representation by the Company or any other person that the results expressed in the statements will be achieved. We do not undertake any obligation to update the forward-looking information herein, which speaks only as of this date.

Recent Developments

Marc Ecko Fragrance License

Effective November 5, 2008, we entered into an exclusive license agreement with Ecko Complex LLC, to develop, manufacture and distribute fragrances under the Marc Ecko marks.  The initial term of the agreement expires on December 31, 2014, and is renewable for an additional three-year term if certain sales levels are met.  We must pay a minimum royalty, whether or not any product sales are made, and spend minimum amounts for advertising based upon sales volume.  We anticipate launching a new fragrance under this license in the fall of 2009 or in the spring of 2010.

Regions Bank Credit Facility

On July 20, 2008, our Loan and Security Agreement (the “Loan Agreement”) with GMAC Commercial Credit LLC (“GMACCC”) expired. On July 22, 2008, along with our subsidiary, Parlux Ltd., we entered into a new Loan and Security Agreement (the “New Loan Agreement”) with Regions Bank (the “Bank”), as lender. The New Loan Agreement provides a credit line of up to $20,000,000, depending upon the availability of a borrowing base, at an interest rate of LIBOR plus 2.00% or the Bank’s prime rate, at our option.

The New Loan Agreement is secured by all of our assets and the assets of our subsidiary, Parlux Ltd. The New Loan Agreement contains customary events of default and covenants which prohibit, among other things, incurring additional indebtedness in excess of a specified amount, paying dividends, creating liens, and engaging in mergers and acquisitions without the prior consent of the Bank. The New Loan Agreement also contains certain financial covenants relating to fixed charge coverage and the ratio of funded debt to EBITDA.

Josie Natori Fragrance License

Effective May 1, 2008, we entered into an exclusive license agreement with J.N. Concepts, Inc., to develop, manufacture and distribute prestige fragrances and related products under the Josie Natori name. The initial term of the agreement expires on September 30, 2012, or December 31, 2012, depending on the first product launch date, and is renewable for an additional three-year term if certain sales levels are met. We must pay a minimum royalty, whether or not any product sales are made, and spend minimum amounts for advertising based upon sales volume. We anticipate launching a new fragrance under this license in the fall of 2009 or early 2010.



2



Queen Latifah Fragrance License

Effective May 22, 2008, we entered into an exclusive license agreement with Queen Latifah Inc., to develop, manufacture and distribute prestige fragrances and related products under the Queen Latifah name. The initial term of the agreement expires on March 31, 2014, and is renewable for an additional five-year term if certain sales levels are met. We must pay a minimum royalty, whether or not any product sales are made, and spend minimum amounts for advertising based upon sales volume. We anticipate launching a new fragrance under this license in the fall of 2009 or early 2010.

Critical Accounting Policies and Estimates

In the ordinary course of business, we have made a number of estimates and assumptions relating to the reporting of results of operations and financial position in the preparation of our financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ significantly from those estimates under different assumptions and conditions. We have included in our Annual Report on Form 10-K for the year ended March 31, 2008, a discussion of our most critical accounting policies, which are those that are most important to the portrayal of our financial condition and results of operations and require management’s most difficult, subjective and complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. We have not made any changes in these critical accounting policies, nor have we made any material ch ange in any of the critical accounting estimates underlying these accounting policies, since the filing of our Annual Report on Form 10-K filing, discussed above.

New Accounting Pronouncements

Effective April 1, 2008, we adopted Statement of Financial Accounting Standards (“SFAS”) No. 157, Fair Value Measurements (“SFAS 157”). SFAS 157 defines fair value, establishes a framework for measuring fair value in accordance with accounting principles generally accepted in the United States of America (“GAAP”), and expands disclosure requirements about fair value measurements. In accordance with the Financial Accounting Standards Board (“FASB”) Staff Position FAS 157-2, Effective Date of FASB Statement No. 157 (“FSP 157-2”), we will defer the adoption of SFAS 157 for our non-financial assets and non-financial liabilities, except those items recognized or disclosed at fair value on an annual or more frequent recurring basis, until April 1, 2009. The adoption of SFAS 157 did not have a material impact on our fair value measurements.

In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities - Including an amendment of FASB No. 115 ("SFAS 159"). SFAS 159 permits companies to choose to measure many financial instruments and certain other items at fair value in order to mitigate volatility in reported earnings caused by measuring related assets and liabilities differently without having to apply complex hedge accounting provisions. SFAS 159 is effective for our fiscal year ending March 31, 2009. We implemented the provisions of SFAS 159 effective April 1, 2008. The adoption of SFAS 159 did not have a material impact on our condensed consolidated financial statements.

In December 2007, the FASB issued SFAS No. 141(R), Business Combinations, or (“SFAS 141(R)”). SFAS 141(R) establishes principles and requirements for how the acquirer of a business recognizes and measures in its financial statements the identifiable assets acquired, the liabilities assumed, and any noncontrolling interest in the acquiree. SFAS 141(R) also provides guidance for recognizing and measuring the goodwill acquired in the business combination and determines what information to disclose to enable users of the financial statements to evaluate the nature and financial effects of the business combination. The provisions of SFAS 141(R) are effective for financial statements issued for fiscal years beginning after December 15, 2008. We are currently assessing the financial impact, if any, of SFAS 141(R) on our condensed consolidated financial statements.

In December 2007, the FASB issued SFAS No. 160, Noncontrolling Interests in Consolidated Financial Statements — An Amendment of ARB No. 51 (“SFAS 160”). SFAS 160 amends Accounting Research Bulletin No. 51, Consolidated Financial Statements (“ARB 51”), to establish accounting and reporting standards for the noncontrolling interest in a subsidiary and for the deconsolidation of a subsidiary. This statement also amends certain of ARB 51’s consolidation procedures for consistency with the requirements of SFAS 141(R). In addition, SFAS 160 also includes expanded disclosure requirements regarding the interests of the parent and its noncontrolling interest. The provisions of SFAS 160 are effective for fiscal years beginning after December 15, 2008. Earlier adoption is prohibited. We are currently assessing the financial impact, if any, of SFAS 160 on our condensed consolidated financial statements.



3



In May 2008, the FASB issued SFAS No. 162, The Hierarchy of Generally Accepted Accounting Principles (“SFAS 162”). The current GAAP hierarchy, as set forth in the American Institute of Certified Public Accountants (“AICPA”) Statement on Auditing Standards No. 69, The Meaning of Present Fairly in Conformity With Generally Accepted Accounting Principles, has been criticized because (1) it is directed to the auditor rather than the entity, (2) it is complex, and (3) it ranks FASB Statements of Financial Accounting Concepts. The FASB believes that the GAAP hierarchy should be directed to entities because it is the entity (not its auditor) that is responsible for selecting accounting principles for financial statements that are presented in conformity with GAAP. Accordingly, the FASB concluded that the GAAP hierarchy should reside in the accounting literature established by the FASB and is issuing this Statement to achieve that result. This Statement is effective 60 days following the SEC’s approval of the Public Company Accounting Oversight Board amendments to AU Section 411, The Meaning of Present Fairly in Conformity With Generally Accepted Accounting Principles. We are currently reviewing the provisions of SFAS 162 to determine the impact, if any, on our condensed consolidated financial statements.

During April 2008, the FASB issued FASB Staff Position (“FSP”) FAS No. 142-3, Determination of the Useful Life of Intangible Assets (“FAS 142-3”). This FSP amends the factors that should be considered in developing renewal or extension assumptions used to determine the useful life of a recognized intangible asset under SFAS No. 142, Goodwill and Other Intangible Assets (“SFAS 142”). The intent of this FSP is to improve the consistency between the useful life of a recognized intangible asset under SFAS 142 and the period of expected cash flows used to measure the fair value of the asset under SFAS 141(R), and other pronouncements under GAAP. FAS 142-3 is effective for financial statements issued for fiscal years beginning after December 15, 2008, and interim periods within those fiscal years. Early adoption is prohibited. We are currently assessing the impact, i f any, of this statement on our condensed consolidated financial statements.

Significant Trends

Over the last few years, a significant number of new prestige fragrance products have been introduced on a worldwide basis. The beauty industry, in general, is highly competitive and consumer preferences often change rapidly. The initial appeal of these new fragrances, launched for the most part in U.S. department stores, has fueled the growth of our industry. Department stores continue to lose sales to the mass market as a product matures. To counter the effect of lower department store sales, companies are required to introduce new products more quickly, which requires additional spending for development and advertising and promotional expenses. In addition, a number of the new launches are with celebrities (either entertainers or athletes) which require substantial royalty commitments and whose careers and/or appeal could change drastically, both positively and negatively, based on a single event. We believe these trends will continue. If one or more of our new product introductions would be unsuccessful, or the appeal of the celebrity would diminish, it could result in a substantial reduction in profitability and operating cash flows.

In addition, certain U.S. department store retailers have consolidated operations resulting in the closing of retail doors as well as implementing various inventory control initiatives. We expect that these store closings, the inventory control initiatives, and the current worldwide economic conditions will continue to affect our sales in the short-term.

Historically, as is the case for most fragrance companies, our sales have been influenced by seasonal trends generally related to holiday or gift giving periods. Substantial sales often occur during the final month of each quarter. This practice assumes activities in future periods will support planned objectives, but there can be no assurance that will be achieved and future periods may be negatively affected.

Results of Operations

As more fully discussed in Note N to the accompanying condensed consolidated financial statements, on December 6, 2006, the Company sold the Perry Ellis fragrance brand license back to Perry Ellis International (PEI) at a price of approximately $63 million, including approximately $21 million for inventory and promotional products relating to the brand. Subsequently, the Perry Ellis brand activity has been presented as discontinued operations and prior period statements of operations have been retrospectively adjusted. The discussions on results of operations that follow are based upon the results from continuing operations and exclude any discussion of discontinued operations, unless specifically noted.



4



We did business with fragrance distributors owned/operated by individuals related to our former Chairman and CEO. Through June 30, 2007, these sales were included as related party sales in the accompanying condensed consolidated statements of operations. As of June 30, 2007, the former Chairman and CEO’s beneficial ownership interest in the Company was approximately 7.6%. During the quarter ended September 30, 2007, his beneficial ownership declined to less than 5%. Accordingly, the Company’s management determined that, effective as of July 1, 2007, transactions with such parties will no longer be reported as related party transactions. As of June 30, 2008, the former Chairman and CEO had no further beneficial ownership interest in the Company.

Our gross margins may not be comparable to other entities that include all of the costs related to their distribution network in costs of goods sold, since we allocate a portion of these distribution costs to costs of goods sold and include the remaining unallocated amounts as selling and distribution expenses. Selling and distribution expenses for the six-months ended September 30, 2008 and 2007, include approximately $2,599,000 and $1,768,000, respectively, ($1,351,000 and $446,000 for the three-months ended September 30, 2008 and 2007) relating to the cost of warehouse operations not allocated to inventories and other related distribution expenses (excluding shipping expenses which are recorded as cost of goods sold). A portion of these costs is allocated to inventory in accordance with accounting principles generally accepted in the United States.

Comparison of the three-month period ended September 30, 2008, with the three-month period ended September 30, 2007.

Net Sales:

During the three-months ended September 30, 2008, net sales from continuing operations increased 40% to $52,392,135, as compared to $37,353,423 for the same prior year period. The increase was primarily due to an increase of $5,839,929 in gross sales of our GUESS? brand fragrances and an increase of $4,119,107 in gross sales of our Paris Hilton brand fragrances, primarily due to the resolution of inventory shortages and delays in obtaining critical components, particularly glass and plastics, experienced in the first quarter of 2009. The increase in Paris Hilton brand fragrances included $1,493,935 in sales of the new Paris Hilton fragrance, Fairy Dust, which launched in late September 2008. In addition, we launched our new Jessica Simpson fragrance, Fancy, in our domestic market in August 2008, resulting in an increase in gross sales of $6,518,343.

Net sales to unrelated customers, which represented 65% of our total net sales for the three-months ended September 30, 2008, increased 89% to $33,822,313, as compared to $17,870,152 for the same prior year period. This was due to an increase in sales to the U.S. department store sector. Net sales to the U.S. department store sector increased 172% to $15,649,547 for the three-months ended September 30, 2008, as compared to $5,760,384 for the same period in the prior year, while net sales to international distributors increased 51% to $18,182,766 from $12,049,768. The increase in domestic sales is primarily due to the launch of our new Jessica Simpson fragrance, Fancy, noted above, and the launch of our new Paris Hilton fragrance, Fairy Dust, which began shipping in our domestic market in August and late September 2008, respectively. The increase in international net sales was the result of the increase in sales of our GUESS? brand fragrances, noted above. Sales to related parties (See Note F to the accompanying condensed consolidated financial statements for further discussion of related parties) decreased 5% to $18,569,822 for the three-months ended September 30, 2008, as compared to $19,483,271 for the same prior year prior.

Cost of Goods Sold:

Our overall cost of goods sold decreased as a percentage of net sales to 46% for the three-months ended September 30, 2008, as compared to 55% for the same prior year period. Cost of goods sold as a percentage of net sales to both unrelated customers and related parties approximated 46% for the three-months ended September 30, 2008, as compared to 60% and 51%, respectively, for the same period in the prior year. The three-months ended September 30, 2008, included a higher percentage of sales to U.S. department store customers, which sales generally have a higher margin than sales of these products to international distributors, which generally reflect a lower margin. As is common in the industry, we offer international customers more generous discounts, which are generally offset by reduced advertising expenditures for those sales, as the international distributors are responsible for advertising in their own terri tories. International distributors have no rights to return merchandise. The prior year comparative period also included the sale of overstock merchandise to related parties, which sales resulted in lower margins.



5



Total Operating Expenses:

Total operating expenses increased by 64% for the three-months ended September 30, 2008, as compared to the same prior year period, to $22,559,120 from $13,725,114, increasing as a percentage of net sales to 43% from 37%. However, certain individual components of our operating expenses experienced more significant changes.

Advertising and Promotional Expenses:

Advertising and promotional expenses increased 177% to $11,721,639 for the three-months ended September 30, 2008, as compared to $4,232,824 for the same prior year period, increasing as a percentage of net sales from 11% to 22%, primarily due to the launches of the new Jessica Simpson and Paris Hilton fragrances in the fall of 2008 and in preparation of the important holiday season. We anticipate that promotional spending for the Jessica Simpson and Paris Hilton brands will continue at these levels during periods which contain new product launches.

Selling and Distribution Costs:

Selling and distribution costs increased 51% to $3,974,844 for the three-months ended September 30, 2008, as compared to $2,639,344 for the same prior year period, increasing as a percentage of sales to 8% from 7%. The increase in costs was mainly attributable to increases in personnel for the Domestic Sales and Marketing departments required to support new product development and in-store activities in anticipation of our launches and the holiday season. In addition, the new Jessica Simpson fragrance, Fancy, was launched in August 2008. Additional selling expenses were incurred with the launch of this new brand.

Royalties:

Royalties increased by 19% to $3,850,369 for the three-months ended September 30, 2008, as compared to $3,226,721 for the same prior year period, decreasing as a percentage of net sales to 7% from 9%. The increase reflects higher royalty payments due to the increase in sales for the three-months ended September 30, 2008. We anticipate that this percentage will remain relatively constant for the remainder of the fiscal year ending March 31, 2009, as increases in fragrance sales partially offset minimum royalty payments for Paris Hilton non-fragrance licenses.

General and Administrative Expenses:

General and administrative expenses decreased 16% to $2,381,400 for the three-months ended September 30, 2008, as compared to $2,819,260 for the same prior year period, decreasing as a percentage of sales to 5% from 8%. The decrease in expenses was mainly attributable to a reduction in the reserves for uncollectible accounts receivable of approximately $568,000, as compared to the same period in the prior year, resulting from the resolution of past due amounts from an international distributor.

Depreciation and Amortization:

Depreciation and amortization decreased 22% to $630,868 for the three-months ended September 30, 2008, as compared to $806,965 for the same prior year period, decreasing as a percentage of sales to 1% from 2%. The decrease was attributable to lower amortization expense. In addition, an impairment charge of $185,232 was recorded in the comparable prior year period in connection with the XOXO fragrance license.

Operating Income:

As a result of the above factors, we generated operating income from continuing operations of $5,785,946 for the three-months ended September 30, 2008, as compared to $3,074,676 for the same period in the prior year.

Net Interest/Income Expense:

Net interest income was $89,217 in the three-months ended September 30, 2008, as compared to net interest expense of $407,658 for the same period in the prior year, as we earned interest on our cash balances and did not need to utilize our line of credit during the three-months ended September 30, 2008.



6



Income Before Income Taxes, Taxes, Discontinued Operations and Net Income:

Our income from continuing operations before income taxes for the three-months ended September 30, 2008, was $5,877,153, as compared to $3,164,279 for the same period in the prior year. Our tax provision reflects an estimated effective rate of 38% for the current year and prior year. As a result, we earned income from continuing operations of $3,643,835 for the three-months ended September 30, 2008, as compared to $1,961,852 in the same prior year period.

Income from discontinued operations (See Note N to the accompanying condensed consolidated financial statements for further discussion), net of the tax effect, was $0 for the three-months ended September 30, 2008, and $69,646 for the comparable prior year period. There was no discontinued operation activity during the three-months ended September 30, 2008.

As a result, we earned net income of $3,643,835 for the three-months ended September 30, 2008, as compared to $2,031,498 for the same prior year period.

Comparison of the six-month period ended September 30, 2008 with the six-month period ended September 30, 2007

Net Sales

During the six-months ended September 30, 2008, net sales from continuing operations increased 10% to $75,696,315, as compared to $68,733,891 for the same prior year period. The increase is mainly attributable to an increase of $11,474,817 in gross sales of our GUESS? brand fragrances, primarily due to the launch of GUESS? by Marciano in February 2008, resulting in gross sales of $6,468,920 during the six-months period, and to the launch of our new Jessica Simpson fragrance, Fancy, in our domestic market in August 2008, resulting in gross sales of $6,518,343, partially offset by a decrease of $8,308,521 in gross sales of our Paris Hilton brand fragrances resulting from delays in obtaining critical components, particularly glass and plastics, experienced in the first quarter of fiscal year 2009.

Net sales to unrelated customers, which represented 73% of our total net sales for the six-months ended September 30, 2008, increased 82% to $55,293,607, as compared to $30,438,659 for the same prior year period, mainly as a result of an increase in gross sales of $13,205,376 to unrelated customers of our GUESS? brand fragrances and an increase in gross sales of $6,518,343 from the launch of our new Jessica Simpson fragrance, Fancy, in our domestic market in August 2008.  Net sales to the U.S. department store sector increased 81% to $21,153,298 for the six-months ended September 30, 2008, as compared to $11,685,336 for the same period in the prior year, while net sales to international distributors increased 82% to $34,140,310 from $18,753,354. The increase in domestic sales is primarily due to the launch of our new Jessica Simpson fragrance, Fancy, noted above, and the launch of our new Paris Hilton fragrance, Fairy Dust, which began shipping in our domestic market in August and late September 2008, respectively. The increase in international net sales was primarily a result of the increase in our GUESS? brand fragrances gross sales of $11,258,503 and an increase in gross sales of $3,616,765 of our Paris Hilton’s Can Can fragrance, which was launched internationally in October of 2007. Sales to related parties decreased 47% to $20,402,708 for the six-months ended September 30, 2008, as compared to $38,295,232 for the same prior year period, mainly as a result of sales of slow-moving and overstocked merchandise in the prior year and certain current unrelated customers being reported as related customers through June 30, 2007.

Effective July 1, 2007, related party sales include only sales to Perfumania, as sales to certain distributors, that were previously reported as related parties, are now included as unrelated international customer sales.

Cost of Goods Sold

Our overall cost of goods sold decreased as a percentage of net sales to 47% for the six-month period ended September 30, 2008, as compared to 52% for the same prior year period. Cost of goods sold as a percentage of net sales to unrelated customers and related parties approximated 48% and 45%, respectively, for the six-month period ended September 30, 2008, as compared to 54% and 51%, respectively, for the same prior year period. The six-month period ended September 30, 2008, includes a higher percentage of sales to U.S. department store customers, which sales generally have a higher margin than sales of these products to international distributors, which generally reflect a lower margin. As is common in the industry, we offer international customers more generous discounts, which are generally offset by reduced advertising expenditures for those sales, as the international distributors are responsible for adverti sing in their own territories. International distributors have no rights to return merchandise.



7



The prior year comparative period also included the sale of overstock merchandise to related parties, which sales resulted in lower margins.

Total Operating Expenses

Total operating expenses increased by 44% for the six-months ended September 30, 2008, as compared to the same period in the prior year, to $42,143,771 from $29,327,917, increasing as a percentage of net sales to 56% from 43%. However, certain individual components of our operating expenses discussed below experienced more significant changes than others.

Advertising and Promotional Expenses

Advertising and promotional expenses increased 90% to $21,364,539 for the six-months ended September 30, 2008, as compared to $11,233,144 for the same prior year period, increasing as a percentage of net sales to 28% from 16%, primarily due to the launches of the new Jessica Simpson and Paris Hilton fragrances in the late summer of 2008 and in preparation of the important holiday season.

Selling and Distribution Costs

Selling and distribution costs increased 55% to $8,104,920 for the six-months ended September 30, 2008, as compared to $5,217,394 for the same prior year period, increasing as a percentage of net sales to 11% from 8%. The increase in costs was mainly attributable to increases in personnel for the Domestic Sales and Marketing departments required to support new product development and in-store activities in anticipation of our new launches and the upcoming holiday season. In addition, the new Jessica Simpson fragrance, Fancy, was launched in August 2008. Additional selling expenses were incurred with the launch of this new brand.

Royalties

Royalties increased by 9% to $6,476,854 for the six-months ended September 30, 2008, as compared to $5,939,062 for the same prior year period, remaining constant as a percentage of net sales at 9%. We anticipate that this percentage will remain relatively constant at 9% or decrease slightly for the remainder of the fiscal year ending March 31, 2009, as increases in fragrance sales partially offset minimum royalties for Paris Hilton non-fragrance licenses.

General and Administrative Expenses

General and administrative expenses decreased 11% to $4,940,899 for the six-months ended September 30, 2008, as compared to $5,524,449 for the same prior year period, decreasing as a percentage of net sales to 7% from 8%. The decrease in expenses was mainly attributable to a decrease in reserves for uncollectible accounts receivable of approximately $640,000, as compared to the same period in the prior year, resulting from the resolution of past due amounts from an international distributor. This was partially offset by an increase in personnel, as noted above.

Depreciation and Amortization

Depreciation and amortization decreased 11% to $1,256,559 for the six-months ended September 30, 2008, as compared to $1,413,868 for the same prior year period, remaining constant at 2% of net sales. The decrease was attributable to lower amortization expense, as an impairment charge of $185,232 was recorded in the comparative prior year period in connection with the XOXO fragrance license.

Operating Income (Loss)

As a result of the above factors, we generated an operating loss from continuing operations of $(2,194,793) for the six-months ended September 30, 2008, as compared to an operating income from continuing operations of $3,442,655 for the same period in the prior year.

Net Interest/Income Expense

Net interest income was $197,430 in the six-months ended September 30, 2008, as compared to net interest expense of $854,327 for the same prior year period, as we did not utilize our line of credit during the current year period.



8



Income (Loss) Before Income Taxes, Income Taxes, Discontinued Operations and Net Income (Loss)

Loss from continuing operations before taxes for the six-months ended September 30, 2008, was $(1,998,381), as compared to income from continuing operations before taxes of $3,084,257 for the same period in the prior year. Our tax benefit in the current year and our tax provision in the prior year reflect an estimated effective tax rate of 38%. Actual tax benefits realized may be greater or less than amounts recorded, and such differences may be material. As a result, we incurred a loss from continuing operations of $(1,238,996) for the six-months ended September 30, 2008, as compared to income of $1,912,239 in the same period of the prior year.

Income from discontinued operations net of the tax effect, was $0 for the six-months ended September 30, 2008, as compared to $21,631 for the same prior year period. (See Note N to the accompanying condensed consolidated financial statements for further discussion).

As a result, we incurred a net loss for the six-months ended September 30, 2008, of $(1,238,996), as compared to net income of $1,933,870 for the same prior year period.

Liquidity and Capital Resources

Working capital decreased to $106,792,952 at September 30, 2008, compared to $107,293,236 at March 31, 2008, primarily due to the use of current assets to support the net loss reported for the six-months ended September 30, 2008.

During the six-months ended September 30, 2008, net cash provided by operating activities was $3,405,245, as compared to $7,705,809 during the same prior year period. The current year activity reflects an increase in trade receivables from unrelated parties resulting from higher net sales and an increase in inventories, accounts payable and accrued expenses in preparation of the holiday season. The prior year activity reflects an increase in trade receivables, along with a decrease in accounts payable and accrued expenses, offset by a refund of income taxes paid in the prior year, decreases in inventories and prepaid expenses and receipt of the remaining balance due from the sale of the Perry Ellis fragrance license.

For the six-months ended September 30, 2008, net cash used in investing activities was $135,797, as compared to net cash provided by investing activities of $140,931 during the same prior year period. The current year activity reflects lower purchases of equipment and trademarks, as compared to the prior year period, and no restricted cash, while the prior year investing activities primarily resulted from a decrease in restricted cash.

During the six-months ended September 30, 2008, net cash used in financing activities was $475,572 as compared to cash used in financing activities of $7,846,007 during the same prior year period. The current year activity reflects the continued repayments of capital leases, while the prior year financing activities was mainly attributable to the repayments of the GMACCC credit facility.

As of September 30, 2008 and 2007, our ratios of the number of days sales in accounts receivable and number of days cost of sales in inventory, on an annualized basis, were as follows:

 

 

 

September 30,

 

 

 

 

2008

 

 

2007

 

Trade accounts receivable: 

 

 

 

 

 

 

 

Unrelated (1)

 

 

 

101

 

 

 

 

114

 

 

Related:

 

 

 

 

 

 

 

 

 

 

 

Perfumania

 

 

 

138

 

 

 

 

121

 

 

Total

 

 

 

111

 

 

 

 

117

 

 

Inventories

 

 

 

285

 

 

 

 

337

 

 

———————

(1)

Calculated on gross trade receivables excluding allowances for doubtful accounts, sales returns and advertising allowances of approximately $6,384,000 and $4,051,000 in 2008 and 2007, respectively.

The decrease in the number of days from 2007 to 2008 for unrelated customers was mainly attributable to successful collections from our distributors in the six months ended September 30, 2008.



9



The number of days sales in trade receivables from Perfumania, Inc. (“Perfumania”) continues to exceed those of unrelated customers, due mainly to their seasonal cash flow (See Note F to the accompanying condensed consolidated financial statements for further discussion of our relationship with Perfumania). However, due to the limited amount of sales to Perfumania during the quarter ended June 30, 2008, and the reclassification of certain distributors previously classified as related parties, the calculated number of days sales in accounts receivable from Perfumania is not indicative of a true aging. The number of days, based upon the actual aging as of September 30, 2008, would be 95 days (116 days at September 30, 2007). Management closely monitors the Company’s activity with Perfumania and holds periodic discussions with Perfumania in order to review their anticipated payments for the each quarte r.

As noted in Note F to the accompanying condensed consolidated financial statements, effective as of July 1, 2007, transactions with such parties formerly identified as related, through their affiliation with our former Chairman and CEO, are no longer reported as related party transactions. Their number of days sales are included with unrelated parties in the current period.

The lead time for certain of our raw materials and components inventory (up to 180 days) requires us to maintain at least a three to six month supply of some items in order to ensure production schedules. In addition, when we launch a new brand or Stock Keeping Unit (“SKU”), we frequently produce a six to nine-month supply to ensure adequate inventories if the new products exceed our forecasted expectations. We believe that the gross margins on our products outweigh the additional carrying costs. However, if future sales do not reach forecasted levels, it could result in excess inventories and may cause us to decrease prices to reduce inventory levels.

Inventory balances are generally higher during our first and second quarters due to increased production in anticipation of the upcoming holiday gift-giving season. Also, during the six-months ended September 30, 2008, we increased our production in anticipation of the launch of the new Jessica Simpson and Paris Hilton fragrances. During July 2008, we commenced shipping of the new Jessica Simpson brand, which was launched domestically during the second quarter of 2008. The new Paris Hilton fragrance was launched in late September 2008. We believe, based upon projected sales, that all inventory will be utilized within the next twelve months.

As of March 31, 2008, we had repurchased, under all phases of our common stock buy-back program, a total of 11,347,377 shares at a cost of $39,176,713. On October 16, 2008, our Board of Directors (the “Board”) approved the reinstatement of our buy-back program, approving the repurchase of 1,000,000 shares, subject to certain limitations, including approval from our new lender. Our new lender’s approval was received on October 24, 2008. As of November 5, 2008, we have repurchased, in the open market, 152,600 shares at a cost of $523,972.

On July 20, 2001, we entered into a Loan and Security Agreement (the “Loan Agreement”) with GMAC Commercial Credit LLC (“GMACCC”). On January 4, 2005, the Loan Agreement was extended through July 20, 2006. Under the Loan Agreement, we were able to borrow, depending upon the availability of a borrowing base, on a revolving basis, up to $20,000,000 at an interest rate of LIBOR plus 2.75% or the Bank of New York’s prime rate, at our option.

On January 10, 2006, the Loan Agreement was amended, increasing the loan amount to $30,000,000, with an additional $5,000,000 available at our option, while extending the maturity to July 20, 2008. The interest was reduced to 0.25% below the prime rate. During May 2006, we exercised our option and increased the line to $35,000,000. On July 20, 2008, the Company’s Loan Agreement with GMACCC expired.

Restricted cash represents collections of trade accounts receivable deposited with our bank and pending transfer to GMACCC. As of March 31, 2008, there were no amounts on deposit with our bank pending transfer.

Through July 20, 2008, substantially all of our assets collateralized the Loan Agreement which contained customary events of default and covenants prohibiting, among other things, incurring additional indebtedness in excess of a specified amount, paying dividends, creating liens, and engaging in mergers and acquisitions without the prior consent of GMACCC. The Loan Agreement also contained certain financial covenants relating to net worth, interest coverage and other financial ratios. On July 20, 2008, our Loan and Security Agreement with GMAC Commercial Credit LLC expired.

On July 22, 2008, we signed a new Loan and Security Agreement (the “New Loan Agreement”) with Regions Bank (“Bank”). The New Loan Agreement provides a credit line of up to $20,000,000, depending upon the availability of a borrowing base, at an interest rate of LIBOR plus 2.00% or the Bank’s prime rate, at our option, of which no amounts were outstanding at September 30, 2008.



10



Restricted cash represents collections of trade accounts receivable deposited with our bank and pending transfer to Regions. As of September 30, 2008, there were no amounts on deposit with our bank pending transfer.

Substantially all of our assets collateralize our New Loan Agreement. The New Loan Agreement contains customary events of default and covenants which prohibit, among other things, incurring additional indebtedness in excess of a specified amount, paying dividends, creating liens, and engaging in mergers and acquisitions without the prior consent of the Bank. The New Loan Agreement also contains certain financial covenants relating to fixed charge coverage and the ratio of funded debt to EBITDA. As of September 30, 2008, we were in compliance with our financial covenants.

As of September 30, 2008, we did not have any “off-balance sheet” arrangements as that term is defined in Regulation S-K 303, nor do we have any material commitments for capital expenditures.

Management believes that funds from operations and our existing financing will be sufficient to meet our current operating and seasonal needs. However, if we were to expand operations through acquisitions, new licensing arrangements or both, we may need to obtain financing. There is no assurance that we could obtain such financing or what the terms of such financing, if available, would be. In addition, the current business environment may increase the difficulty of obtaining new financing, if needed.

Contractual Obligations

There were no material changes during the quarter ended September 30, 2008, in our contractual obligations previously disclosed in our Annual Report on Form 10-K for the year ended March 31, 2008.

Item 3.

Quantitative and Qualitative Disclosures About Market Risks.

During the quarter ended September 30, 2008, there have been no material changes to our exposures to market risks since March 31, 2008. Please refer to our Annual Report on Form 10-K for the year ended March 31, 2008, for a complete discussion of our exposures to market risk.

Item 4.

Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

We carried out an evaluation under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this Quarterly Report. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this Quarterly Report.

Changes in Internal Control

Based on an evaluation, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, there has been no change in our internal control over financial reporting during our last fiscal quarter, identified in connection with that evaluation, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.




11



PART II. – OTHER INFORMATION

Item 1.

Legal Proceedings.

Litigation

On June 21, 2006, we were served with a stockholder derivative action (the “Derivative Action”) filed in the Circuit Court of the Seventeenth Judicial Circuit in and for Broward County, Florida by NECA-IBEW Pension Fund, purporting to act derivatively on behalf of the Company.

The Derivative Action named Parlux Fragrances, Inc. as a defendant, along with Ilia Lekach, Frank A. Buttacavoli, Glenn Gopman, Esther Egozi Choukroun, David Stone, Jaya Kader Zebede and Isaac Lekach, each of whom at that date was one of our directors. The Derivative Action related to the proposal from PF Acquisition of Florida LLC (“PFA”), which was owned by Ilia Lekach, to acquire all of the Company’s outstanding shares of common stock for $29.00 ($14.50 after the Stock Split) per share in cash (the “Proposal”).

The Derivative Action seeks to remedy the alleged breaches of fiduciary duties, waste of corporate assets, and other violations of law and seeks injunctive relief from the Court appointing a receiver or other truly neutral third party to conduct and/or oversee any negotiations regarding the terms of the Proposal, or any alternative transaction, on behalf of Parlux and its public shareholders, and to report to the Court and plaintiff’s counsel regarding the same. The Derivative Action alleges that the unlawful plan to attempt to buy out the public shareholders of Parlux without having proper financing in place, and for inadequate consideration, violates applicable law by directly breaching and/or aiding the other defendants’ breaches of their fiduciary duties of loyalty, candor, due care, independence, good faith and fair dealing, causing the complete waste of corporate assets, and constituting an abuse of control by the defendants. Before any response to the original complaint was due, counsel for plaintiffs indicated that an amended complaint would be filed. That First Amended Complaint (the "Amended Complaint") was served to the Company’s counsel on August 17, 2006.

The Amended Complaint continues to name the then Board of Directors as defendants along with Parlux, as a nominal defendant. The Amended Complaint is largely a collection of claims previously asserted in a 2003 derivative action, which the plaintiffs in that action, when provided with additional information, simply elected not to pursue. It adds to those claims, assertions regarding a 2003 buy-out effort and the recently abandoned buy-out effort of PFA. It also contains allegations regarding the prospect that our stock might be delisted because of a delay in meeting Securities and Exchange Commission (“SEC”) filing requirements. It relies in large measure on a bevy of media articles rather than facts known to the plaintiffs.

We and the other defendants engaged Florida securities counsel, including the counsel who successfully represented us in the previous failed derivative action, and on September 18, 2006, moved to dismiss the Amended Complaint. A Second Amended Complaint was filed on October 26, 2006, which added alleged violations of securities laws, which we moved to dismiss on December 1, 2006. A hearing on the dismissal was held on March 8, 2007. On March 22, 2007, the motion to dismiss was denied and the defendants were provided twenty (20) days to respond, and a response was filed on March 29, 2007. Since that time there has been extremely limited discovery conducted in the case. Some documents have been produced. Narrow interrogatories were answered. There have been no depositions and none has even been scheduled. A number of the factual allegations upon which the various complaints were based have fallen away, simply by op eration of time. A number of months ago, we were advised that one of the two plaintiffs was withdrawing from the case. No explanation was given. The remaining plaintiff then spent several months obtaining documents from our former auditors. The documents provide no support for any of the claims.

We then sought to take the deposition of the remaining plaintiff, who lives in Seattle. He declined to travel due to a long-standing “fear of flying” and filed a motion on August 4, 2008, for a protective order from the Court. The Court denied the motion and required him to appear here in Florida for his deposition. As a consequence of this ruling, his counsel then informed us that this plaintiff, too, was withdrawing from the case due to this travel requirement, leaving no plaintiff. We were then served with a motion on September 15, 2008, to further amend the complaint by inserting a new plaintiff. Our counsel is opposing that motion, which appears procedurally flawed, since a person not a party to the case has no standing to move to amend the complaint. A hearing on that motion is schedule for late December 2008.



12



Based on the allegations in the Second Amended Complaint, upon the information collected in the earlier litigation and upon the information provided in response to the limited discovery noted above, it is believed that the Second Amended Complaint is without merit.

Other

To the best of the Company’s knowledge, there are no other proceedings threatened or pending against the Company, which, if determined adversely to the Company, would have a material effect on the Company’s financial position or results of operations and cash flows.

Item 1A.

Risk Factors.

There were no material changes during the quarter ended September 30, 2008, in the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended March 31, 2008.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3.

Defaults on Senior Securities.

None.

Item 4.

Submission of Matters to a Vote of Security Holders.

The Company did not submit any actions for shareholder approval during the quarter ended September 30, 2008.

Item 5.

Other Information.

None.

Item 6.

Exhibits.

Exhibit #

 

Description

4.1

 

Loan and Security Agreement, dated as of July 22, 2008, between Parlux Fragrances, Inc. and Parlux Ltd., and Regions Bank (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the SEC on July 25, 2008).

31.1

 

Certification of Chief Executive Officer Pursuant to §302 of the Sarbanes-Oxley Act of 2002.

31.2

 

Certification of Chief Financial Officer Pursuant to §302 of the Sarbanes-Oxley Act of 2002.

32.1

 

Certification of Chief Executive Officer Pursuant to §906 of the Sarbanes-Oxley Act of 2002.

32.2

 

Certification of Chief Financial Officer Pursuant to §906 of the Sarbanes-Oxley Act of 2002.




13



PARLUX FRAGRANCES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

 

 

September 30
2008

 

March 31,
2008

 

 

 

(unaudited)

 

 

 

 

ASSETS

 

 

 

   

 

 

 

CURRENT ASSETS:

 

 

 

 

 

 

 

Cash and cash equivalents

     

$


24,202,043

     

$

21,408,167

 

Trade receivables, net of allowance for doubtful accounts, sales returns and advertising allowances of approximately $6,384,000 and $4,487,000, respectively

 

 

24,081,583

 

 

19,301,061

 

Trade receivables from related parties

 

 

15,356,233

 

 

15,392,112

 

Income tax receivable

 

 

3,614,572

 

 

2,743,694

 

Inventories

 

 

55,673,201

 

 

48,068,280

 

Prepaid expenses and other current assets, net

 

 

12,338,227

 

 

11,343,286

 

Deferred tax assets, net

 

 

3,883,888

 

 

4,076,358

 

TOTAL CURRENT ASSETS

 

 


139,149,747

 

 

122,332,958

 

Equipment and leasehold improvements, net

 

 

3,402,254

 

 

4,093,091

 

Trademarks and licenses, net

 

 

2,340,286

 

 

2,770,211

 

Deferred tax assets, net

 

 

1,619,071

 

 

1,619,071

 

Other

 

 

270,438

 

 

332,609

 

TOTAL ASSETS

 

$

146,781,796

 

$

131,147,940

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

 

 

 

Borrowings, current portion

 

$

1,027,190

 

$

990,953

 

Accounts payable

 

 

26,745,098

 

 

11,447,992

 

Accrued expenses

 

 

4,584,507

 

 

2,600,777

 

TOTAL CURRENT LIABILITIES

 

 

32,356,795

 

 

15,039,722

 

Borrowings, less current portion

 

 

18,063

 

 

542,633

 

TOTAL LIABILITIES

 

 

32,374,858

 

 

15,582,355

 

COMMITMENTS AND CONTINGENCIES

 

 

 

 

 

 

 

STOCKHOLDERS' EQUITY :

 

 

 

 

 

 

 

Preferred stock, $0.01 par value, 5,000,000 shares authorized, no shares
issued and outstanding at September 30, 2008 and March 31, 2008

 

 

 

 

 

Common stock, $0.01 par value, 30,000,000 shares authorized,
29,978,789 shares issued at September 30, 2008 and 29,977,289
shares issued at March 31, 2008

 

 

299,788

 

 

299,773

 

Additional paid-in capital

 

 

101,534,025

 

 

101,575,691

 

Retained earnings

 

 

46,633,158

 

 

47,926,973

 

 

 

 

148,466,971

 

 

149,802,437

 

Less 9,297,377 and 9,397,377 shares of common stock in treasury,
at cost, at September 30, 2008 and March 31, 2008, respectively

 

 

(34,060,033

)

 

(34,236,852

)

TOTAL STOCKHOLDERS' EQUITY

 

 

114,406,938

 

 

115,565,585

 

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

 

$

146,781,796

 

$

131,147,940

 




See notes to condensed consolidated financial statements.


14



PARLUX FRAGRANCES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

 

Three Months Ended
September 30,

 

 

Six Months Ended
September 30,

 

 

 

2008

 

 

2007

 

 

2008

 

 

2007

 

Net sales:

     

 

 

     

 

 

     

 

 

     

 

 

Unrelated customers, including licensing fees of $18,750 and $37,500 for the three and six months ended
September 30, 2008 and 2007, respectively

 

$

33,822,313

 

 

$

17,870,152

 

 

$

55,293,607

 

 

$

30,438,659

 

Related parties

 

 

18,569,822

 

 

 

19,483,271

 

 

 

20,402,708

 

 

 

38,295,232

 

 

 

 

52,392,135

 

 

 

37,353,423

 

 

 

75,696,315

 

 

 

68,733,891

 

Cost of goods sold:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrelated customers

 

 

15,462,367

 

 

 

10,659,401

 

 

 

26,619,597

 

 

 

16,524,506

 

Related parties

 

 

8,584,702

 

 

 

9,894,232

 

 

 

9,127,740

 

 

 

19,438,813

 

  

 

 

24,047,069

 

 

 

20,553,633

 

 

 

35,747,337

 

 

 

35,963,319

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Advertising and promotional

 

 

11,721,639

 

 

 

4,232,824

 

 

 

21,364,539

 

 

 

11,233,144

 

Selling and distribution

 

 

3,974,844

 

 

 

2,639,344

 

 

 

8,104,920

 

 

 

5,217,394

 

Royalties

 

 

3,850,369

 

 

 

3,226,721

 

 

 

6,476,854

 

 

 

5,939,062

 

General and administrative, including share-based compensation expense of $33,794 for the three and $67,588 for the six months ended September 30, 2008

 

 

2,381,400

 

 

 

2,819,260

 

 

 

4,940,899

 

 

 

5,524,449

 

Depreciation and amortization

 

 

630,868

 

 

 

806,965

 

 

 

1,256,559

 

 

 

1,413,868

 

Total operating expenses

 

 

22,559,120

 

 

 

13,725,114

 

 

 

42,143,771

 

 

 

29,327,917

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income (loss)

 

 

5,785,946

 

 

 

3,074,676

 

 

 

(2,194,793

)

 

 

3,442,655

 

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

 

111,585

 

 

 

 

 

 

245,912

 

 

 

93

 

Interest expense and bank charges

 

 

(22,368

)

 

 

(407,658

)

 

 

(48,482

)

 

 

(854,420

)

Other income

 

 

 

 

 

497,771

 

 

 

 

 

 

497,771

 

Foreign exchange gain (loss)

 

 

1,990

 

 

 

(510

)

 

 

(1,018

)

 

 

(1,842

)

Income (loss) from continuing operations before income taxes

 

 

5,877,153

 

 

 

3,164,279

 

 

 

(1,998,381

)

 

 

3,084,257

 

Income tax (provision) benefit

 

 

(2,233,318

)

 

 

(1,202,427

)

 

 

759,385

 

 

 

(1,172,018

)

Income (loss) from continuing operations

 

 

3,643,835

 

 

 

1,961,852

 

 

 

(1,238,996

)

 

 

1,912,239

 

Discontinued operations:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from operations of Perry Ellis fragrance brand

 

 

 

 

 

112,331

 

 

 

 

 

 

34,888

 

Income tax provision related to Perry Ellis brand

 

 

 

 

 

(42,685

)

 

 

 

 

 

(13,257

)

Income from discontinued operations

 

 

 

 

 

69,646

 

 

 

 

 

 

21,631

 

Net income (loss)

 

$

3,643,835

 

 

$

2,031,498

 

 

$

(1,238,996

)

 

$

1,933,870

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

0.18

 

 

$

0.10

 

 

$

(0.06

)

 

$

0.10

 

Discontinued operations

 

$

0.00

 

 

$

0.00

 

 

$

0.00

 

 

$

0.00

 

Total

 

$

0.18

 

 

$

0.10

 

 

$

(0.06

)

 

$

0.10

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

0.17

 

 

$

0.10

 

 

$

(0.06

)

 

$

0.09

 

Discontinued operations

 

$

0.00

 

 

$

0.00

 

 

$

0.00

 

 

$

0.00

 

Total

 

$

0.17

 

 

$

0.10

 

 

$

(0.06

)

 

$

0.09

 




See notes to condensed consolidated financial statements.


15



PARLUX FRAGRANCES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY

SIX MONTHS ENDED SEPTEMBER 30, 2008

(UNAUDITED)

 

 

Common Stock

 

Additional
Paid-In
Capital

 

Retained
Earnings

 

Treasury Stock

 

Total

 

Number
Issued

 

Par
Value

Number
of Shares

 

Cost

BALANCE at March 31, 2008

     

 

29,977,289

 

$

299,773

 

$

101,575,691

 

$

47,926,973

 

 

9,397,377

 

$

(34,236,852

)

$

115,565,585

 

Net loss

 

 

 

 

 

 

 

 

(1,238,996

)

 

 

 

 

 

(1,238,996

)

Excess tax deficiency

 

 

 

 

 

 

(114,189

)

 

     

 

     

 

     

 

(114,189

)

Issuance of common stock upon exercise of warrants

 

 

1,500

     

 

15

     

 

4,935

     

 

 

 

 

 

 

 

4,950

 

Issuance of common stock from treasury shares upon exercise of warrants

 

 

 

 

 

 

 

 

(54,819

)

 

(100,000

)

 

176,819

 

 

122,000

 

Share-based compensation from option grants

 

 

 

 

 

 

67,588

 

 

 

 

 

 

 

 

67,588

 

BALANCE at September 30, 2008

 

 

29,978,789

 

$

299,788

 

$

101,534,025

 

$

46,633,158

 

 

9,297,377

 

$

(34,060,033

)

$

114,406,938

 




See notes to condensed consolidated financial statements.


16



PARLUX FRAGRANCES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

 

Six Months Ended September 30,

 

 

 

2008

 

 

2007

 

 

 

 

 

 

 

 

Cash flows from operating activities:

     

 

 

     

 

 

Net (loss) income

 

$

(1,238,996

)

 

$

1,933,870

 

 

 

 

 

 

 

 

 

 

Adjustments to reconcile net (loss) income to net cash

 

 

 

 

 

 

 

 

 provided by operating activities:

 

 

 

 

 

 

 

 

Share-based compensation expense

 

 

67,588

 

 

 

 

Depreciation and amortization

 

 

1,256,559

 

 

 

1,413,868

 

(Recovery) provision for doubtful accounts

 

 

(12,700

)

 

 

628,719

 

Write downs of prepaid promotional supplies and inventories

 

 

(28,090

)

 

 

570,000

 

Deferred income tax provision

 

 

192,470

 

 

 

 

Changes in assets and liabilities:

 

 

 

 

 

 

 

 

Increase in trade receivables - customers

 

 

(4,767,822

)

 

 

(8,947,215

)

Decrease (increase) in trade receivables - related parties

 

 

35,879

 

 

 

(6,032,830

)

Decrease in receivable from sale of fragrance brand

 

 

 

 

 

2,272,233

 

(Increase) decrease in income tax receivable

 

 

(870,878

)

 

 

5,739,255

 

(Increase) decrease in inventories

 

 

(7,090,296

)

 

 

2,934,615

 

(Increase) decrease in prepaid expenses and other current assets

 

 

(1,481,476

)

 

 

3,899,474

 

Decrease in inventories, non-current

 

 

 

 

 

3,902,862

 

Decrease in deferred tax asset

 

 

 

 

 

2,447,224

 

Decrease in other non-current assets

 

 

62,171

 

 

 

107,234

 

Increase (decrease) in accounts payable

 

 

15,297,106

 

 

 

(2,627,672

)

Increase (decrease) in accrued expenses and income taxes payable

 

 

1,983,730

 

 

 

(535,828

)

Total adjustments

 

 

4,644,241

 

 

 

5,771,939

 

 

Net cash provided by operating activities

 

 

3,405,245

 

 

 

7,705,809

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Net decrease in restricted cash

 

 

 

 

 

522,643

 

Purchases of equipment and leasehold improvements, net

 

 

(80,424

)

 

 

(195,986

)

Purchases of trademarks

 

 

(55,373

)

 

 

(185,726

)

  

Net cash (used in) provided by investing activities

 

 

(135,797

)

 

 

140,931

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Repayments - line of credit with GMACCC, net

 

 

 

 

 

(7,956,110

)

Repayments on capital leases

 

 

(488,333

)

 

 

(454,550

)

Excess tax deficiency resulting from exercise of warrants

 

 

(114,189

)

 

 

(1,187,177

)

Proceeds from issuance of common stock

 

 

4,950

 

 

 

595,888

 

Proceeds from issuance of common stock from treasury shares

 

 

122,000

 

 

 

1,155,942

 

  

Net cash used in financing activities

 

 

(475,572

)

 

 

 (7,846,007

)

Effect of exchange rate changes on cash

 

 

 

 

 

 

Net increase in cash and cash equivalents

 

 

2,793,876

 

 

 

733

 

Cash and cash equivalents, beginning of period

 

 

21,408,167

 

 

 

14,271

 

Cash and cash equivalents, end of period

 

$

 24,202,043

 

 

$

15,004

 




See notes to condensed consolidated financial statements.


17



PARLUX FRAGRANCES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

A.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements include the accounts of Parlux Fragrances, Inc., and its wholly-owned subsidiaries, Parlux, S.A., a French company (“S.A.”) and Parlux Ltd. (jointly referred to as the “Parlux”, “Company”, “us”, and “we”). All material intercompany balances and transactions have been eliminated in consolidation.

The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and note disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been omitted pursuant to those rules and regulations, although the Company believes that the disclosures made herein are adequate to make the information presented not misleading. The financial information presented herein, which is not necessarily indicative of results to be expected for the current fiscal year, reflects all adjustments (consisting only of normal recurring accruals), which, in the opinion of management, are necessary for a fair presentation of the interim unaudited condensed consolidated financial statements. It is suggested that these condens ed consolidated financial statements be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended March 31, 2008, as filed with the SEC on June 9, 2008.

B.

Share-Based Compensation, Stock Options and Other Plans

On October 11, 2007, the Company’s stockholders approved the Parlux Fragrances, Inc. 2007 Stock Incentive Plan (the “2007 Plan”), which reserved an additional 1,500,000 shares of common stock for equity-based awards to employees, officers, directors, consultants and/or independent contractors of the Company. The 2007 Plan was adopted by the Board of Directors on June 20, 2007, subject to stockholder approval and the shares underlying the options were registered with the Securities and Exchange Commission on a Form S-8 registration statement declared effective on December 28, 2007.

On October 11, 2007, the Company granted 240,000 options under the 2007 Plan to certain executives in connection with their July 2007 employment agreements, and 75,000 options (15,000 each) to its five non-employee directors, to acquire common stock during a five-year period at $4.60 per share, the closing price of stock on October 11, 2007. The directors’ options vested on the grant date, while the executives’ options vest over a three-year period at the annual rate of 40,000, 80,000 and 120,000, respectively. The fair value of the combined October 11, 2007, options was determined to be $728,784. The directors’ options were expensed in full as share-based compensation during the prior year, while the executives’ options are being expensed as share-based compensation over a three-year period in accordance with the applicable vesting periods.

The fair value of these options at the date of grant was estimated using a Black-Scholes option pricing model with the following weighted average assumptions.

Expected life (years)

 

 

3

 

Expected volatility

 

 

70

%

Risk-free interest rate

 

 

6

%

Dividend yield

 

 

0

%

Additionally, the Company has two stock option plans which provide for equity-based awards to its employees other than its directors and officers (collectively, the "Employee Plans"). Under the Employee Plans, the Company reserved 1,000,000 shares of common stock; 470,774 options (including 102,850 granted during August 2007 discussed below) were granted of which 369,774 were exercised. All stock options had an exercise price that was equal to the fair market value of the Company's stock on the date the options were granted. The term of the stock option awards is five years from the date of grant. In addition, the Company had previously issued 3,440,000 warrants to certain officers, employees, consultants and directors (384,000 of which are outstanding at September 30, 2008), all of which were granted at or in excess of the market value of the underlying shares at the date of grant, and are exercisable for a ten-ye ar period.



18



On August 22, 2007, the Company granted, to various employees, options under the Employee Plans to acquire 102,850 shares of common stock at $3.30 per share, the closing price of the stock on August 21, 2007. These options have a life of five years from the date of grant (or thirty days after termination for any reason), and vest 25% after each of the first two years, and 50% after the third year. The fair value of the options was determined to be $170,536, which will be expensed as share-based compensation over a three year period in accordance with the vesting period of the options. On September 22, 2008, the Company granted, to an employee, options under the Employee Plans to acquire 2,500 shares of common stock at $5.55 per share, the closing price of the stock on September 22, 2008, with the same term and conditions noted above. As of September 30, 2008, 3,100 stock options were forfeited by terminated employees.

The fair value of these options at the date of grant was estimated using a Black-Scholes option pricing model with the following weighted average assumptions.

Expected life (years)

 

 

3

 

Expected volatility

 

 

70

%

Risk-free interest rate

 

 

6

%

Dividend yield

 

 

0

%

The expected life of all of the various options and warrants represented the estimated period of time until exercise based on historical experience of similar awards, giving consideration to the remaining contractual terms and expectations of future employee behavior. The expected volatility was estimated using the historical volatility of the Company's stock, which management believes is the best indicator at this time. The risk-free interest rate was based on the implied yield available on U.S. Treasury zero coupon issues with an equivalent term. The Company has not paid dividends in the past and does not intend to in the foreseeable future.

Included in general and administrative expenses for the six-months ended September 30, 2008, is $67,588 of share-based compensation relating to the options issued in August and October 2007.

A summary of stock option and warrant activity during the six-months ended September 30, 2008, follows:

 

 

Number of

Shares

 

Weighted

Average

Exercise

Price

 

Weighted

Average

Remaining

Contractual

Life

 

Aggregate

Intrinsic

Value

 

Outstanding as of March 31, 2008

     

 

901,850

     

$

2.64

     

 

3.57

     

$

826,400

 

Granted

 

 

2,500

 

$

5.55

 

 

5.00

 

 

 

Exercised

 

 

(101,500

)

$

1.25

 

 

3.01

 

$

(211,595

)

Forfeited

 

 

(3,100

)

$

3.30

 

 

4.25

 

 

 

Outstanding as of September 30, 2008

 

 

799,750

 

$

2.83

 

 

3.15

 

$

1,850,080

 

Exercisable as of September 30, 2008

 

 

523,563

 

$

2.07

 

 

3.91

 

$

1,606,495

 

Prior to July 24, 2007, upon exercise of options and warrants, the Company issued previously authorized but unissued common stock to the holders. Commencing July 24, 2007, upon exercise the Company issued shares from treasury shares to the holders, including the 100,000 warrants exercised during the first quarter of fiscal 2009. The difference between the original cost of the treasury shares ($176,819) and the proceeds received from the warrant holder ($122,000) was recorded as a reduction in retained earnings.  

The intrinsic value of the warrants exercised during the six-months ended September 30, 2008, was approximately $211,595 and the tax benefit from the exercise of such warrants is expected to approximate $80,000 for income tax purposes. As of March 31, 2008, a deferred tax benefit of $192,470 was provided on these warrants in connection with the share-based compensation charge from fiscal 2007. During the six-months ended September 30, 2008, the Company adjusted the deferred tax asset and reduced additional paid-in capital by $114,189 as a result of the exercise.



19



The following table summarizes information about the options and warrants outstanding at September 30, 2008, of which 523,563 are exercisable:

 

 

Options and Warrants Outstanding

 

Range of
Exercise Prices

 

Amount

 

Weighted Average
Exercise Price

 

Weighted Average
Remaining Contractual Life

 

Aggregate
Intrinsic
Value

 

$1.04

-

$1.22

 

 

364,000

 

$1.20

 

2.09

 

$

1,432,400

 

 

 

$1.80

 

 

20,000

 

$1.80

 

4.50

 

 

66,800

 

 

 

$3.30

 

 

98,250

 

$3.30

 

4.00

 

 

180,780

 

 

 

$4.60

 

 

315,000

 

$4.60

 

4.00

 

 

170,100

 

 

 

$5.55

 

 

2,500

 

$5.55

 

5.00

 

 

 

 

 

 

 

 

799,750

 

$2.83

 

3.15

 

$

1,850,080

 

Proceeds relating to the exercise of all options and warrants during the six-months ended September 30, 2008 and 2007, were $126,950 and $1,751,830, respectively.

On October 16, 2008, the Company granted 75,000 options (15,000 each, which vested on the grant date) under the 2007 Plan to its five non-employee directors, to acquire common stock during a five-year period at $3.70 per share, the closing price of the stock on October 16, 2008. The fair value of the options was determined to be $158,572, which will be expensed during the quarter ending December 31, 2008.

The fair value of these options at the date of grant was estimated using a Black-Scholes option pricing model with the following weighted average assumptions.

Expected life (years)

 

 

4

 

Expected volatility

 

 

70

%

Risk-free interest rate

 

 

6

%

Dividend yield

 

 

0

%

C.

Inventories

The components of inventories are as follows:

 

 

September 30,

2008

 

March 31,

2008

Finished products:

 

 

 

 

 

 

Fragrances

 

$

30,903,577

 

$

28,625,862

Watches

 

 

2,197,297

 

 

2,390,603

Handbags

 

 

100,449

 

 

377,917

Components and packaging material: 

 

 

 

 

 

 

Fragrances

 

 

18,643,386

 

 

14,889,115

Watches

 

 

19,289

 

 

25,343

Raw material

 

 

3,809,203

 

 

1,759,440

 

 

$

55,673,201

 

$

48,068,280

As is more fully described in Note J, in December 2006 one of the Company’s licensors, GUESS? Inc., brought an action against the Company alleging that GUESS? fragrance products were being sold in unauthorized retail channels. The Company entered into a settlement agreement with GUESS? that, among other things, requires pre-approval of each international customer to whom the Company sells GUESS? fragrances. If the Company were to be found in breach of its agreement with GUESS?, at any point in the future, some of the remedies that they could pursue would include the termination or modification of the license agreement.

As of September 30, 2008, our inventories of GUESS? products totaled $18.2 million ($22.8 million at March 31, 2008). If the licensing agreement were to be terminated or modified at any time in the future, the Company may be required to record charges to operations to reduce the recorded value of such inventories to the amounts which would be realized upon their sale or liquidation.




20



D.

Trademarks and Licenses

Trademarks and licenses are attributable to the following brands:

 

 

September 30,

2008

 

March 31,
2008

 

Estimated
Life

(in years)

XOXO

 

$

4,285,495

 

 

4,285,495

 

5

Fred Hayman Beverly Hills (“FHBH”)

  

 

2,820,361

 

 

2,820,361

  

10

Paris Hilton

 

 

799,497

 

 

744,124

 

5

Other

 

 

216,546

 

 

216,546

 

5-25

 

 

 

8,121,899

 

 

8,066,526

 

 

Less – accumulated amortization

 

 

(5,781,613

)

 

(5,296,315

)

 

 

 

$

2,340,286

 

$

2,770,211

 

 

During the years ended March 31, 2008 and 2007, the Company recorded impairment charges of $385,232 and $1,129,273, respectively, in connection with the XOXO license as the estimated future net cash flows for the remaining period of the license were determined to be less than the license’s carrying value. There were no impairment charges recorded during the six-months ended September 30, 2008. During the six-months ended September 30, 2007, the Company recorded an impairment charge of $185,232.

E.

Borrowings

The composition of borrowings is as follows:

 

 

September 30,

2008

 

March 31,

2008

 

Revolving credit facility payable to GMAC Commercial Credit LLC, interest at LIBOR plus 2.75% or prime minus 0.25% at the Company’s option.

 

$

 

$

 

Revolving credit facility payable to Regions Bank, interest at LIBOR plus 2.00% or prime at the Company’s option.

 

 

 

 

 

Capital leases payable to Provident Equipment Leasing, collateralized by certain equipment and leasehold improvements, payable in equal quarterly installments of $257,046, including imputed interest at 7.33%, through July 2009.

 

 

988,478

 

 

1,456,266

 

Capital lease payable to IBM, collateralized by certain computer equipment, payable in equal monthly installments of $3,648, including imputed interest at 3.94%, through December 2009.

 

 

56,775

 

 

77,320

 

 

 

 

1,045,253

 

 

1,533,586

 

Less: long-term borrowings

 

 

18,063

 

 

542,633

 

Borrowings, current portion

 

$

1,027,190

 

$

990,953

 

On July 20, 2001, the Company entered into a Loan and Security Agreement (the “Loan Agreement”) with GMAC Commercial Credit LLC (“GMACCC”). On January 4, 2005, the Loan Agreement was extended through July 20, 2006. Under the Loan Agreement, the Company was able to borrow, depending on the availability of a borrowing base, on a revolving basis, up to $20,000,000 at an interest rate of LIBOR plus 2.75% or the Bank of New York’s prime rate, at the Company’s option.

On January 10, 2006, the Loan Agreement was amended, increasing the loan amount to $30,000,000 with an additional $5,000,000 available at the Company’s option. In addition, the maturity was extended through July 20, 2008, and the interest rate was reduced to 0.25% below the prime rate. During May 2006, the Company exercised its option and increased the line of credit to $35,000,000.

On September 13, 2006, the Loan Agreement was further amended, temporarily increasing the loan amount to $40,000,000 until December 13, 2006, at which time the maximum loan amount reverted back to $35,000,000.

At June 30, 2008, based on the borrowing base at that date, available borrowing under the credit line amounted to approximately $21,537,000, of which none (none as of March 31, 2008) was utilized.



21



As of July 20, 2008, substantially all of the assets of the Company, excluding the New Jersey warehouse equipment discussed below, collateralized the credit line borrowing. The Loan Agreement contained customary events of default and covenants which prohibit, among other things, incurring additional indebtedness in excess of a specified amount, paying dividends, creating liens, and engaging in mergers and acquisitions without the prior consent of GMACCC. The Loan Agreement also contained certain financial covenants relating to net worth, interest coverage and other financial ratios. On July 20, 2008, the Company’s Loan Agreement with GMACCC expired.

On July 22, 2008, the Company signed a new Loan and Security Agreement (the “New Loan Agreement”) with Regions Bank (the “Bank”). The New Loan Agreement provides up to $20,000,000, depending upon the availability of a borrowing base, at an interest rate of LIBOR plus 2.00% or the Bank’s prime rate, at the Company’s option, of which no amounts were outstanding at September 30, 2008.

Substantially all of the Company’s assets collateralize the New Loan Agreement. The New Loan Agreement contains customary events of default and covenants which prohibit, among other things, incurring additional indebtedness in excess of a specified amount, paying dividends, creating liens, and engaging in mergers and acquisitions without the prior consent of the Bank. The New Loan Agreement also contains certain financial covenants relating to fixed charge coverage and the ratio of funded debt to EBITDA. As of September 30, 2008, we were in compliance with our financial covenants.

During May 2006, the Company entered into an agreement with Provident Equipment Leasing (“Provident”) covering approximately $2,761,000 of certain warehouse equipment and leasehold improvements to be purchased for the Company’s new leased distribution center in New Jersey. Provident advanced, on behalf of the Company, progress payments to various suppliers based on the work completed. In accordance with the terms of the agreement, the advances bore interest at a rate of 1% per month until all payments were made, at which time the arrangement converted to a thirty-six month lease, which has been classified as a capital lease. The Company has an option to purchase the equipment and leasehold improvements at the end of the lease term for $1.

On December 15, 2006, the Company entered into a lease agreement with International Business Machines (“IBM”) covering approximately $124,000 of computer equipment which has been classified as a capital lease. The Company has an option to purchase the computer equipment at the end of the lease term for $1.

The Company believes that funds from operations and its existing financing will be sufficient to meet the Company’s current operating and seasonal needs. However, if the Company was to expand operations through acquisitions, new licensing arrangements or both, the Company may need to obtain financing. There is no assurance that the Company could obtain such financing or what the terms of such financing, if available, would be. In addition, the current business environment may increase the difficulty of obtaining new financing, if needed.

F.

Related Party Transactions

Related party transactions include the following balances:

 

September 30,

2008

 

March 31,

2008

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable from related parties:

 

 

 

 

 

 

 

 

 

 

 

 

Perfumania

$

15,356,233

 

$

15,392,112

 

 

 

 

 

 

 

Other related parties

 

 

 

 

 

 

 

 

 

 

 

$

15,356,233

 

$

15,392,112

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended
September 30,

 

Six Months Ended
September 30,

 

 

2008

 

2007

 

2008

 

2007

 

Sales from continuing operations to
related parties:

 

 

 

 

 

 

 

 

 

 

 

 

Perfumania

$

18,569,822

 

$

19,483,271

 

$

20,402,708

 

$

30,290,318

 

Other related parties

 

 

 

 

 

 

 

8,004,914

 

 

$

18,569,822

 

$

19,483,271

 

$

20,402,708

 

$

38,295,232

 

The Company had net sales from continuing operations of $20,402,708 and $30,290,318 during the six-month periods ended September 30, 2008 and 2007, respectively, ($18,569,822 and $19,483,271 during the three- months ended September 30, 2008 and 2007, respectively), to Perfumania, Inc. (“Perfumania”), a wholly-owned



22



subsidiary of Perfumania Holdings, Inc., formerly known as E Com Ventures, Inc., a company in which the Company’s former Chairman and Chief Executive Officer had an ownership interest and held identical management positions until February 2004. Perfumania is one of the Company’s largest customers, and transactions with them are closely monitored by management, and any unusual trends or issues are brought to the attention of the Company’s Audit Committee and Board of Directors. Perfumania offers the Company the opportunity to sell its products in approximately 322 retail outlets and its terms with Perfumania take into consideration the relationship existing between the companies for over 15 years. Pricing and terms with Perfumania reflect (a) the volume of Perfumania’s purchases, (b) a policy of no returns from Perfumania, (c) minimal spending for advertising and promotion, (d) exposure of the Company’s products provided in Perfumania’s store windows and (e) minimal distribution costs to fulfill Perfumania orders shipped directly to their distribution center.

Perfumania Holdings, Inc.’s majority shareholders acquired an approximate 12.2% (at that time, and 9.9% at September 30, 2008) ownership interest in the Company during August and September 2006, and accordingly, transactions with Perfumania will continue to be presented as related party transactions.

While the Company’s invoice terms to Perfumania are stated as net ninety days, for over ten years, management has granted longer payment terms, taking into consideration the factors discussed above. Management evaluates the credit risk involved, which is determined based on Perfumania’s reported results and comparable store sales performance. Management monitors the account activity to ensure compliance with their limits. Net trade accounts receivable owed by Perfumania to the Company totaled $15,356,233 and $15,392,112 at September 30, 2008, and March 31, 2008, respectively.

Prior to July 1, 2007, sales to parties related to the Company’s former Chairman and CEO were treated as related party sales. During the year ended March 31, 2008, the former Chairman and CEO’s beneficial ownership interest in the Company declined to less than 5% (0% at September 30, 2008). Accordingly, effective July 1, 2007, transactions with parties related to the former Chairman and CEO are no longer considered to be related party transactions. During the six-months ended September 30, 2007, net sales to related parties included $8,004,914 from these customers.

G.

Basic and Diluted Earnings Per Common Share

The following is the reconciliation of the numerators and denominators of the basic and diluted net income per common share calculations:

 

 

Three Months Ended
September 30,

 

 

 

2008

 

2007

 

Income from continuing operations

 

$

3,643,835

 

$

1,961,852

 

Income from discontinued operations

 

 

 

 

69,646

 

Net income

 

$

3,643,835

 

$

2,031,498

 

Weighted average number of shares issued

 

 

29,977,697

 

 

29,968,485

 

Weighted average number of treasury shares

 

 

(9,297,377

)

 

(10,931,725

)

Weighted average number of shares outstanding used in basic earnings per share calculation

 

 

20,680,320

 

 

19,036,760

 

Basic net income per common share – continuing operations

 

$

0.18

 

$

0.10

 

Basic net income per common share – discontinued operations

 

$

0.00

 

$

0.00

 

Weighted average number of shares outstanding used in basic earnings per share calculation

 

 

20,680,320

 

 


19,036,760

 

Effect of dilutive securities:

 

 

 

 

 

 

 

Stock options and warrants

 

 

418,080

 

 

1,449,266

 

Weighted average number of shares outstanding used in diluted earnings per share calculation

 

 

21,098,400

 

 

20,486,026

 

Diluted net income per common share – continuing operations

 

$

0.17

 

$

0.10

 

Diluted net income per common share – discontinued operations

 

$

0.00

 

$

0.00

 



23




 

 

Six Months Ended
September 30,

 

 

 

2008

 

2007

 

(Loss) income from continuing operations

 

$

(1,238,996

)

$

1,912,239

 

Income from discontinued operations

 

 

 

 

21,631

 

Net (loss) income

 

$

(1,238,996

)

$

1,933,870

 

Weighted average number of shares issued

 

 

29,977,494

 

 

29,713,409

 

Weighted average number of treasury shares

 

 


(9,318,142

)

 

(11,138,415

)

Weighted average number of shares outstanding used in basic and fully
diluted earnings per share calculation

 

 

20,659,352

 

 

18,574,994

 

Basic and fully diluted net (loss) income per common share – continuing operations(1)

 

$

(0.06

)

$

0.10

 

Basic and fully diluted net income per common share – discontinued
operations(1)

 

$

0.00

 

$

0.00

 

Weighted average number of shares outstanding used in basic earnings per share calculation

 

 

20,659,352

 

 


18,574,994

 

Effect of dilutive securities:

 

 

 

 

 

 

 

Stock options and warrants

 

 

 

 

1,846,237

 

Weighted average number of shares outstanding used in diluted earnings per share calculation(1)

 

 

20,659,352

 

 

20,421,231

 

Diluted net (loss) income per common share – continuing operations

 

$

(0.06

)

$

0.09

 

Diluted net income per common share – discontinued operations(1)

 

$

0.00

 

$

0.00

 

Antidilutive securities not included in diluted earnings
per share computation: (1)

 

 

 

 

 

 

 

Options and warrants to purchase common stock

 

 

799,750

 

 

 

Exercise price

 

$

1.04 to $5.55

 

$

 

———————

(1)

In accordance with paragraph 15 of Statement of Financial Accounting Standards (“SFAS”) No. 128, Earnings Per Share, the number of shares utilized in the calculation of diluted (loss) earnings per share from continuing operations, discontinued operations and net income were the same as those used in the basic calculation of earnings per share for the six-months ended September 30, 2008, as we incurred a loss from continuing operations for that period.

H.

Cash Flow Information

The Company considers temporary investments with an original maturity of three months or less to be cash equivalents. Supplemental disclosures of cash flow information are as follows:

 

 

Six Months Ended
September 30,

 

 

 

2008

 

2007

 

Cash paid for: 

 

 

 

 

 

 

 

Interest

 

$

48,482

 

$

854,420

 

Income taxes

 

$

34,440

 

$

132,950

 


I.

Income Taxes for Continuing Operations

The tax (provision)/benefit for the periods reflect an estimated effective rate of 38%. Actual tax benefits realized may be greater or less than the amounts recorded, and such differences may be material. Income tax receivable at September 30, 2008, includes $2,743,694 of recoverable income taxes previously paid and $870,878 of estimated recoverable income taxes that will be offset by estimated income tax payable at year-end.



24



J.

License and Distribution Agreements

During the six-months ended September 30, 2008, the Company held exclusive worldwide licenses to manufacture and sell fragrance and other related products for Paris Hilton, GUESS?, Jessica Simpson, Nicole Miller, Josie Natori, Queen Latifah, Ocean Pacific (“OP”), Andy Roddick, babyGund, and XOXO. During December 2006, the Company sold its Perry Ellis licensing rights and other related assets to Perry Ellis International, its licensor. See Note N for further discussion. On June 30, 2008, the Company’s license with Maria Sharapova expired. The Company elected not to renew this contract. The Company has until December 31, 2008, to sell-off any remaining inventory on hand.

On January 7, 2005, the Company entered into a purchase and sale agreement, effective January 6, 2005, (the “Purchase Agreement”) with Victory International (USA), LLC (“Victory”), whereby it acquired the exclusive worldwide licensing rights, along with inventories, molds, designs and other assets, relating to the XOXO fragrance brand. As consideration, Victory was paid approximately $7.46 million, of which $2.55 million was in the form of a 60-day promissory note payable in two equal installments on February 6, and March 6, 2005. The payments were made as scheduled.

On December 1, 2003, Victory had entered into a license agreement with Global Brand Holdings, LLC (the “Fragrance License”) to manufacture and distribute XOXO branded fragrances. The first XOXO fragrances were introduced by Victory during December 2004. Under the Purchase Agreement, Victory assigned its rights, and the Company assumed the obligations, under the Fragrance License. During June 2006, the Company negotiated renewal terms which, among other items, reduced minimum royalty requirements and have extended the Fragrance License for an additional three years through June 30, 2010.

On January 26, 2005, the Company entered into an exclusive worldwide license agreement with Paris Hilton Entertainment, Inc. (“PHEI”), to develop, manufacture and distribute watches and other time pieces under the Paris Hilton name. The initial term of the agreement expires on June 30, 2010, and is renewable for an additional five-year period. The first “limited edition” watches under this agreement were launched during December 2005 and a line of “fashion watches” were launched during spring 2006.

Effective April 6, 2005, the Company entered into an exclusive license agreement with GUND, Inc., to develop, manufacture and distribute children’s fragrances and related products on a worldwide basis under the babyGund trademark. The agreement continues through June 2010, and is renewable for an additional two years if certain sales levels are met.

On May 11, 2005, the Company entered into an exclusive worldwide license agreement with PHEI, to develop, manufacture and distribute cosmetics under the Paris Hilton name. The initial term of the agreement expires on January 15, 2011, and is renewable for an additional five-year period. To date, no products have been launched under this license.

On May 13, 2005, the Company entered into an exclusive worldwide license agreement with PHEI, to develop, manufacture and distribute handbags, purses, wallets and other small leather goods, under the Paris Hilton name. The initial term of the agreement expires on January 15, 2011, and is renewable for an additional five-year period. The first products under this agreement were launched during summer 2006. During fiscal 2008, the Company sublicensed the international rights under this license.

On April 5, 2006, the Company entered into an exclusive worldwide license agreement with PHEI, to develop, manufacture and distribute sunglasses under the Paris Hilton name. The initial term of the agreement expires on January 15, 2012, and is renewable for an additional five-year period. To date, no products have been launched under this license.

Under all of these license agreements, we must pay a minimum royalty, whether or not any product sales are made, and spend minimum amounts for advertising based on sales volume. Except as discussed below, the Company believes it is presently in compliance with all material obligations under the above agreements.

In December 2006, the Company received a complaint from GUESS?, Inc. (“GUESS?”) alleging that GUESS? fragrance products were being sold in unauthorized retail channels. Although the Company did not sell such products directly to these channels, it still represents a violation of the Company’s license agreement with GUESS?. On May 7, 2007, the Company entered into a settlement agreement with GUESS? which, among other items, requires GUESS?’s reapproval of all international distributors selling GUESS? fragrance products, liquidating



25



damages in the amount of $500,000, payable in nine equal monthly installments of $55,556, as well as requiring the Company to strictly monitor distribution channels. Any further violations surrounding unapproved distribution could result in termination of the license agreement. During the quarter ended March 31, 2007, the Company suspended shipments to international distributors. GUESS? has subsequently approved certain international distributors and the Company has commenced shipments to these approved distributors. The Company continues to submit approval requests for additional international distributors in accordance with procedures outlined in the license agreement.

On June 21, 2007, the Company entered into an exclusive license agreement with VCJS, LLC, to develop, manufacture and distribute prestige fragrances and related products under the Jessica Simpson name. The initial term of the agreement expires five years from the date of the first product sales and is renewable for an additional five years if certain sales levels are met. The Company must pay a minimum royalty, whether or not any product sales are made, and spend minimum amounts for advertising based upon sales volume. The Company launched the first fragrance under this agreement during August 2008.

On August 1, 2007, the Company entered into an exclusive license agreement with Kobra International, Ltd., to develop, manufacture and distribute prestige fragrances and related products under the Nicole Miller name. The initial term of the agreement expires on September 30, 2013, and is renewable for two additional terms of three years each, if certain sales levels are met. The Company must pay a minimum royalty, whether or not any product sales are made, and spend minimum amounts for advertising based upon sales volume. The Company anticipates launching a new fragrance under this license in the spring of 2009, and has resumed the manufacturing of certain previously developed Nicole Miller fragrances.

Effective May 1, 2008, the Company entered into an exclusive license agreement with J.N. Concepts, Inc., to develop, manufacture and distribute prestige fragrances and related products under the Josie Natori name. The initial term of the agreement expires on September 30, 2012, or December 31, 2012, depending on the first product launch date, and is renewable for an additional three-year term if certain sales levels are met. The Company must pay a minimum royalty, whether or not any product sales are made, and spend minimum amounts for advertising based upon sales volume. The Company anticipates launching a new fragrance under this license in the fall of 2009 or early 2010.

Effective May 22, 2008, the Company entered into an exclusive license agreement with Queen Latifah Inc., to develop, manufacture and distribute prestige fragrances and related products under the Queen Latifah name. The initial term of the agreement expires on March 31, 2014, and is renewable for an additional five-year term if certain sales levels are met. The Company must pay a minimum royalty, whether or not any product sales are made, and spend minimum amounts for advertising based upon sales volume. The Company anticipate launching a new fragrance under this license in the fall of 2009 or early 2010.

K.

Segment Information

Prior to the quarter ended December 31, 2005, the Company operated in one industry segment as a manufacturer and distributor of prestige fragrances and beauty related products. During December 2005 and March 2006, the Company commenced sales of watches and handbags, respectively, both of which are under license agreements with Paris Hilton Entertainment, Inc. Revenues from the sale of watches and handbags during the six- months ended September 30, 2008, totaled $1,101,199 and $56,958, respectively ($1,050,659 and $290,068 for the six-months ended September 30, 2007, respectively). Included in inventories at September 30, 2008, is approximately $2,216,586 and $100,449 relating to watches and handbags, respectively ($2,415,946 and $377,917 for watches and handbags at March 31, 2008). The Company anticipates preparing full segment disclosure if these operations become more significant.

L.

Legal Proceedings

Litigation

On June 21, 2006, the Company was served with a stockholder derivative action (the “Derivative Action”) filed in the Circuit Court of the Seventeenth Judicial Circuit in and for Broward County, Florida by NECA-IBEW Pension Fund, purporting to act derivatively on behalf of the Company.



26



The Derivative Action named Parlux Fragrances, Inc. as a defendant, along with Ilia Lekach, Frank A. Buttacavoli, Glenn Gopman, Esther Egozi Choukroun, David Stone, Jaya Kader Zebede and Isaac Lekach, each of whom at that date was one of our directors. The Derivative Action related to the proposal from PF Acquisition of Florida LLC (“PFA”), which was owned by Ilia Lekach, to acquire all of the Company’s outstanding shares of common stock for $29.00 ($14.50 after the Stock Split) per share in cash (the “Proposal”).

The Derivative Action seeks to remedy the alleged breaches of fiduciary duties, waste of corporate assets, and other violations of law and seeks injunctive relief from the Court appointing a receiver or other truly neutral third party to conduct and/or oversee any negotiations regarding the terms of the Proposal, or any alternative transaction, on behalf of Parlux and its public shareholders, and to report to the Court and plaintiff’s counsel regarding the same. The Derivative Action alleges that the unlawful plan to attempt to buy out the public shareholders of Parlux without having proper financing in place, and for inadequate consideration, violates applicable law by directly breaching and/or aiding the other defendants’ breaches of their fiduciary duties of loyalty, candor, due care, independence, good faith and fair dealing, causing the complete waste of corporate assets, and constituting an abuse of control by the defendants. Before any response to the original complaint was due, counsel for plaintiffs indicated that an amended complaint would be filed. That First Amended Complaint (the "Amended Complaint") was served to the Company’s counsel on August 17, 2006.

The Amended Complaint continues to name the then Board of Directors as defendants along with Parlux, as a nominal defendant. The Amended Complaint is largely a collection of claims previously asserted in a 2003 derivative action, which the plaintiffs in that action, when provided with additional information, simply elected not to pursue. It adds to those claims, assertions regarding a 2003 buy-out effort and the recently abandoned buy-out effort of PFA. It also contains allegations regarding the prospect that the Company's stock might be delisted because of a delay in meeting Securities and Exchange Commission (“SEC”) filing requirements.

The Company and the other defendants engaged Florida securities counsel, including the counsel who successfully represented the Company in the previous failed derivative action, and on September 18, 2006, moved to dismiss the Amended Complaint. A Second Amended Complaint was filed on October 26, 2006, which added alleged violations of securities laws, which the Company moved to dismiss on December 1, 2006. A hearing on the dismissal was held on March 8, 2007. On March 22, 2007, the motion to dismiss was denied and the defendants were provided twenty (20) days to respond, and a response was filed on March 29, 2007. Since that time there has been extremely limited discovery conducted in the case. Some documents have been produced. Narrow interrogatories were answered. There have been no depositions and none has even been scheduled. A number of the factual allegations upon which the various complaints were based hav e fallen away, simply by operation of time. A number of months ago, the Company was advised that one of the two plaintiffs was withdrawing from the case. No explanation was given. The remaining plaintiff then spent several months obtaining documents from our former auditors. The documents provide no support for any of the claims.

The Company then sought to take the deposition of the remaining plaintiff, who lives in Seattle. He declined to travel due to a long-standing “fear of flying” and filed a motion on August 4, 2008, for a protective order from the Court. The Court denied the motion and required him to appear here in Florida for his deposition. As a consequence of this ruling, his counsel then informed us that this plaintiff, too, was withdrawing from the case due to this travel requirement, leaving no plaintiff. The Company was then served with a motion on September 15, 2008, to further amend the complaint by inserting a new plaintiff. Our counsel is opposing that motion, which appears procedurally flawed, since a person not a party to the case has no standing to move to amend the complaint. A hearing on that motion is schedule for late December 2008.

Based on the allegations in the Second Amended Complaint, upon the information collected in the earlier litigation and upon the information provided in response to the limited discovery noted above, it is believed that the Second Amended Complaint is without merit.

Management believes that the ultimate outcome of these matters will not have a material effect on the Company’s financial position or results of operations.

M.

New Accounting Pronouncement

Effective April 1, 2008, we adopted SFAS No. 157, Fair Value Measurements (“SFAS 157”). SFAS 157 defines fair value, establishes a framework for measuring fair value in accordance with accounting principles generally accepted in the United States of America (“GAAP”), and expands disclosure requirements about fair value



27



measurements. In accordance with the Financial Accounting Standards Board (“FASB”) Staff Position FAS 157-2, Effective Date of FASB Statement No. 157 (“FSP 157-2”), we will defer the adoption of SFAS 157 for our non-financial assets and non-financial liabilities, except those items recognized or disclosed at fair value on an annual or more frequent recurring basis, until April 1, 2009. The adoption of SFAS 157 did not have a material impact on our fair value measurements.

In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities - Including an amendment of FASB No. 115 ("SFAS 159"). SFAS 159 permits companies to choose to measure many financial instruments and certain other items at fair value in order to mitigate volatility in reported earnings caused by measuring related assets and liabilities differently without having to apply complex hedge accounting provisions. SFAS 159 is effective for the Company's fiscal year ending March 31, 2009. The Company adopted the provisions of SFAS 159 effective April 1, 2008. The adoption of SFAS 159 did not have a material impact on our condensed consolidated financial statements.

In December 2007, the FASB issued SFAS No. 141(R), Business Combinations, or (“SFAS 141(R)”). SFAS 141(R) establishes principles and requirements for how the acquirer of a business recognizes and measures in its financial statements the identifiable assets acquired, the liabilities assumed, and any noncontrolling interest in the acquiree. SFAS 141(R) also provides guidance for recognizing and measuring the goodwill acquired in the business combination and determines what information to disclose to enable users of the financial statements to evaluate the nature and financial effects of the business combination. The provisions of SFAS 141(R) are effective for financial statements issued for fiscal years beginning after December 15, 2008. We are currently assessing the financial impact, if any, of SFAS 141(R) on our condensed consolidated financial statements.

In December 2007, the FASB issued SFAS No. 160, Noncontrolling Interests in Consolidated Financial Statements — An Amendment of ARB No. 51 (“SFAS 160”). SFAS 160 amends Accounting Research Bulletin No. 51, Consolidated Financial Statements (“ARB 51”), to establish accounting and reporting standards for the noncontrolling interest in a subsidiary and for the deconsolidation of a subsidiary. This statement also amends certain of ARB 51’s consolidation procedures for consistency with the requirements of SFAS 141(R). In addition, SFAS 160 also includes expanded disclosure requirements regarding the interests of the parent and its noncontrolling interest. The provisions of SFAS 160 are effective for fiscal years beginning after December 15, 2008. Earlier adoption is prohibited. We are currently assessing the financial impact, if any, of SFAS 160 on our condensed consolidated financial statements.

In May 2008, the FASB issued SFAS No. 162, The Hierarchy of Generally Accepted Accounting Principles (“SFAS 162”). The current GAAP hierarchy, as set forth in the American Institute of Certified Public Accountants (“AICPA”) Statement on Auditing Standards No. 69, The Meaning of Present Fairly in Conformity With Generally Accepted Accounting Principles, has been criticized because (1) it is directed to the auditor rather than the entity, (2) it is complex, and (3) it ranks FASB Statements of Financial Accounting Concepts. The FASB believes that the GAAP hierarchy should be directed to entities because it is the entity (not its auditor) that is responsible for selecting accounting principles for financial statements that are presented in conformity with GAAP. Accordingly, the FASB concluded that the GAAP hierarchy should reside in the accounting literature established by the FASB and is issuing t his Statement to achieve that result. This Statement is effective 60 days following the SEC’s approval of the Public Company Accounting Oversight Board amendments to AU Section 411, The Meaning of Present Fairly in Conformity With Generally Accepted Accounting Principles. We are currently reviewing the provisions of SFAS 162 to determine the impact, if any, on our condensed consolidated financial statements.

During April 2008, the FASB issued FASB Staff Position (FSP) FAS No. 142-3, Determination of the Useful Life of Intangible Assets (“FAS 142-3”). This FSP amends the factors that should be considered in developing renewal or extension assumptions used to determine the useful life of a recognized intangible asset under FASB Statement No. 142, Goodwill and Other Intangible Assets (“SFAS 142”). The intent of this FSP is to improve the consistency between the useful life of a recognized intangible asset under SFAS 142 and the period of expected cash flows used to measure the fair value of the asset under SFAS 141(R), and other pronouncements under GAAP. FAS 142-3 is effective for financial statements issued for fiscal years beginning after December 15, 2008, and interim periods within those fiscal years. Early adoption is prohibited. We are currently assessing the impact, if any, of the statement on our condensed consolidated financial statements.



28



N.

Discontinued Operations

On November 28, 2006, the Company’s Board of Directors approved the sale of the Perry Ellis fragrance brand license back to Perry Ellis International (“PEI”) at a price of approximately $63 million, including approximately $21 million for inventory and promotional products relating to the brand. A definitive agreement was signed on December 6, 2006, and the closing took place shortly thereafter. The sale included all inventory, promotional products, molds and other intangibles. The transaction generated proceeds of approximately $63 million, and resulted in a pre-tax gain of approximately $34.3 million.

Beginning with the quarter ended December 31, 2006, the Perry Ellis brand activity has been presented as discontinued operations. Prior period statements of operations have been retrospectively adjusted. The activity for this discontinued operation is summarized as follows:

 

Three Months Ended

September 30,

 

 

Six Months Ended

September 30,

 

 

2008

 

2007

 

 

2008

 

2007

 

Net revenues

$

 

$

56,236

 

 

$


 

$

36,150

 

Operating income

$

 

$

112,331

 

 

$


 

$

34,888

 

Income from discontinued operations

$

 

$

69,646

 

 

$


 

$

21,631

 

O.

Subsequent Events

Effective November 5, 2008, the Company entered into an exclusive license agreement with Ecko Complex LLC, to develop, manufacture and distribute fragrances under the Marc Ecko marks.  The initial term of the agreement expires on December 31, 2014, and is renewable for an additional three-year term if certain sales levels are met.  The Company must pay a minimum royalty, whether or not any product sales are made, and spend minimum amounts for advertising based upon sales volume.  The Company anticipates launching a new fragrance under this license in the fall of 2009 or in the spring of 2010.

On October 16, 2008, our Board of Directors (the “Board”) approved the reinstatement of our buy-back program, approving the repurchase of 1,000,000 shares, subject to certain limitations, including approval from our new lender. Our new lender’s approval was received on October 24, 2008. As of November 5, 2008, we have repurchased, in the open market, 152,600 shares at a cost of $523,972.

* * * *



29



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

PARLUX FRAGRANCES, INC.

 

 

 

/s/ NEIL J. KATZ

 

Neil J. Katz, Chairman and Chief Executive Officer

(Principal Executive Officer)

 

 

 

 

/s/ RAYMOND J. BALSYS

 

Raymond J. Balsys, Chief Financial Officer

(Principal Financial and Principal Accounting Officer)

 

 

Date: November 6, 2008



30



EXHIBIT INDEX

Exhibit #

 

Description


 

 

31.1

 

Certification of Chief Executive Officer Pursuant to §302 of the Sarbanes-Oxley Act of 2002.

31.2

 

Certification of Chief Financial Officer Pursuant to §302 of the Sarbanes-Oxley Act of 2002.

32.1

 

Certification of Chief Executive Officer Pursuant to §906 of the Sarbanes-Oxley Act of 2002.

32.2

 

Certification of Chief Financial Officer Pursuant to §906 of the Sarbanes-Oxley Act of 2002.







EX-31.1 2 exhibit311.htm CERTIFICATION EXHIBIT 31



EXHIBIT 31.1

CERTIFICATIONS PURSUANT TO

RULE 13A-14 OF THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002


I, Neil J. Katz, certify that:

1.

I have reviewed this quarterly report on Form 10-Q of Parlux Fragrances, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and  have:

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Dated: November 6, 2008


 

/s/ Neil J. Katz

                                                                                                      

Neil J. Katz,

 

Chairman and Chief Executive Officer




EX-31.2 3 exhibit312.htm CERTIFICATION EXHIBIT 31

EXHIBIT 31.2

CERTIFICATIONS PURSUANT TO

RULE 13A-14 OF THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002


I, Raymond J. Balsys, certify that:

1.

I have reviewed this quarterly report on Form 10-Q of Parlux Fragrances, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and  have:

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)

Disclosed in this report any change in the registrant’s internal control over  financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.





Dated: November 6, 2008

 

/s/ Raymond J. Balsys

 

Raymond J. Balsys,

Chief Financial Officer







EX-32.1 4 exhibit321.htm CERTIFICATION EXHIBIT 32

EXHIBIT 32.1

 

CERTIFICATIONS PURSUANT TO CHAPTER 63 OF TITLE 18 U.S.C. SECTION 1350 AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Parlux Fragrances, Inc. (the "Company") on Form 10-Q for the period ending September 30, 2008 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Neil J. Katz, Chief Executive Officer of the Company, certify, pursuant to Chapter 63 of Title 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

 

 

By:

/s/ Neil J. Katz

 

 

Neil J. Katz

 

 

Chairman and Chief Executive Officer

 

 

 

November 6, 2008

 




EX-32.2 5 exhibit322.htm CERTIFICATION EXHIBIT 32

EXHIBIT 32.2

 

 

CERTIFICATIONS PURSUANT TO CHAPTER 63 OF TITLE 18 U.S.C. SECTION 1350 AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

 

In connection with the Quarterly Report of Parlux Fragrances, Inc. (the "Company") on Form 10-Q for the period ending September 30, 2008, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Raymond J. Balsys, Chief Financial Officer of the Company, certify, pursuant to Chapter 63 of Title 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 


 November 6, 2008

                                                                        

By:

/s/ Raymond J. Balsys

 

 

Raymond J. Balsys,

Chief Financial Officer

 




-----END PRIVACY-ENHANCED MESSAGE-----